Pediatride Hastane Kaynaklı Enfeksiyonlardan Korunma

Pediatri hastane pratiğinde hastane enfeksiyonları HE ve kontrolü önemli bir konudur. Her bir enfeksiyon için hastanede yatış süresini ortalama 10-15 gün arttırır ve böylece morbidite, mortalite ve yatış masraflarına önemli ölçüde etkisi olur. HE kontrol stratejileri, sağlık hizmeti veren herkesi etkiler. HE azaltmak için öncelikle sorunun boyutlarını belirlemek gerekir. Sürekli ve hedefe yönelik sürveyansın uygulanması mevcut HE sıklığı, özellikleri ve sorunu çözücü yaklaşımların belirlenmesini sağlar Tablo 1 ve 2 . izolasyon uygulamaları ve standart önlemler hastalar arası ve sağlık çalışanıyla hasta arasındaki enfeksiyonun yayılmasını önlemede en etkin yoldur. El yıkama veya susuz el yı- kama olarak tabir edilebilen alkol esaslı temizleyici ajanlarla el temizliği HE kontrol pratiğinde en önemli yoldur. Mümkün olduğu kadar risk faktörlerini azaltmak, antibiyotiklerin akılcı kullanımı, eğitim ve uygulanabilir kontrol programları, HE nin kontrol altında tutulmasına katkı sağlar. Bu yazıda HE korunması hakkında genel yaklaşım ve pediatrik hastalara yönelik daha ayrıntılı özelliklerden bahsedilecektir.

___

  • 1. Rangel-Frausto S. Isolation of communicable diseases. In: Wenzel RP, Brewer T, Butzler JP (eds). A Guide to Infection Control in the Hospital. Boston. Bc Decker, 2002; 6-10.
  • 2. Wenzel RP. Handwashing. In:Wenzel RP, Brewer T, Butzler JP (eds). A Guide to Infection Control in the Hospital. Boston. Bc Decker, 2002; 4- 5.
  • 3. Fisher MC. Nosocomial Infections and Infection Control. In: Jenson HB, Baltimore RS (eds). Pediatric Infectious Dis 2nd Ed. Philadelphia, WB Saunders, 2002; 1221-41.
  • 4. Huskins WC, Goldmann DA. Prevention and control of nosocomial infections in healthy care facilities that serve children. In:Feigin RD, Cherry JD, Demmler GJ, Kaplan SL (eds). Textbook of Pediatric Infectious Diseases Philadelphia, Saunders, 2004; 2924-41.
  • 5. Boyce JM, Kelliher S, Vallande N. Skin irritation and dryness associated with two hand-hygiene regimens: Soap-and-water hand washing versus hand antisepsis with an alcoholic hand gel. Infect Control Hosp Epidemiol. 2000; 21:442-8.
  • 6. Centers for Disease Control and Prevention: Guideline for hand hygiene in health-care settings: Recommendations of the Healthcare Infection Control Practices Advisory Committee and HIPAC/SHEA/APIC/IDSA Hand Hygiene Task Force. MMWR. Recomm. Rep. 2002; 51(RR-16): 1- 48.
  • 7. Korniewicz DM, Kirwin M, Cresci K and Larson E. Leakage of latex and vinyl exam gloves in high and low risk clinical settings. Am ‹nd Hyg Assoc J. 1993; 54:22-6.
  • 8. Pittet D, Dharan S, Touveneau S, et al. Bacterial contamination of the hands of hospital staff during routine patient care. Arch. Intern Med. 1999;159:821-6.
  • 9. Maury E, Aizieu M, Baudel JR, et al. Availability of an alcohol solution can improve hand disinfection compliance in an intensive care unit. Am J Respir Crit Care Med 2000; 162:324-7.
  • 10. Pittet D, Hugonnet S, Harbarth S, et al. Effectiveness of a hospital-wide programme to inprove compliance with hand hygiene: infection control programme. Lancet 2000; 356:1307-12.
  • 11. Neely M, Toltzis P. Infection control in pediatric hospitals. Curr Opin Infect Dis 2003; 14:449-53.
  • 12. Moolenaar RL, Crutcher JM, San Joaquin VH, et al. A prolonged outbreak of Pseudomonas aeruginosa in a neonatal intensive care unit: did staff fingernails play a role in disease transmission? Infect Control Hosp Epidemiol 2000; 21:80-5.
  • 13. McKinley KJ, Larson EL, Leyden JJ. Composition and density of microflora in the subungual space of the hand. J Lin Microbiol 1988; 26; 950- 3.
  • 14. McNeil SA, Foster CL, Hedderwick SA, Kauffman CA. Effect of hand cleansing with antimicrobial soap or alcohol based gel on microbial colonization of artificial fingernails worn by health care workers. Clin Infect Dis 2001; 32:367-72.
  • 15. Apisarnthanarak A, Holzmann-Pazgal G, Hamvas A, Olsen MA, Fraser VJ. Ventilator-Associated pneumonia in extremely preterm neonates in a neonatal intensive care unit: characteristics, risk factors and outcomes. Pediatrics Vol.112. 2003; 6:1283.
  • 16. Yogev R. Central nervous System Shunt infections. In: Jenson HB, Baltimore RS (eds). Pediatric Infectious Dis 2nd Ed. Philadelphia, WB Saunders, 2002; 651-56.
  • 17. Haines SJ, Walters BC. Antibiotic prophylaxis for cerebrospinal fluid shunts: a meta-analysis. Neurosurgery 1994: 34: 87-93.
  • 18. Raymond J, Aujard Y. Nosocomial infections in pediatric patients: a European, multicenter prospective study. European Study Group. Infect Control Hosp Epidemiol 2000; 21:260-3.
  • 19. Cunney RJ, Bialachowski A, Thornley D, et al. An outbreak of influenza A in a neonatal intensive care unit. Infect Control Hosp Epidemial 2000; 21:449-54.
  • 20. Hall CB, Douglas RG. Modes of transmission of respiratory syncytial virus. J Pediatr 1981; 99:100-3.
  • 21. Macartney KK, Gorelick MH, Manning ML, et al. Nosocomial respiratory syncytial virus infections: the cost-effectiveness and cost-benefit of infection control. Pediatrics 2000; 106: 520-6.
  • 22. Kayserling HL, Sinkowitz -Cochran RL, Harris II JM, Levine GL, Siegel JD, Stover BH, Lau SA, Jarvis WR and Pediatric Prevention Network. Vancomycin Use in Hospitalized Pediatric Patients. Pediatrics. Vol 112. 2003; 2: 104.
  • 23. Centers for Disease Control and Prevention. Staphylococcus aureus resistant to vancomycin-United States, 2002. MMWR. 2002; 51: 565-7.
  • 24. Das I, Gray J. Enterrococcal bacteremia in children: a review of seventy-five episodes in a pediatric hospital. Pediatr Infect Dis J 1998; 17:1154-8.
  • 25. Gray JW, George RH. Experience of vancomycin-resistant enterococci in a children's hospital. J Hos Infect 2000; 45:11-8.
  • 26. Malik RK, Montecalvo MA, Reale MR, et al. Epidemiology and control of vancomycin-resistant enterococci in a regional neonatal intensive care unit. Pediatr Infect Dis J 1999; 18:352-6.
  • 27. Donskey CJ, Chowdhry TK, Hecker MT, et al. Effect of antibiotic therapy on the density of vancomycin-resistant enterococci in the stool of colonized patients. N Engl J Med 2000; 343:1925-32.
  • 28. Sohn AH, Jarvis WR. Benchmarking in Pediatric Infection Control: Results from the National Nosocomial Infections Surveillance (NNIS) System and the Pediatric Prevention Network. Semin Pediatr Infect Dis 2001; 12:254-65.
  • 29. Hughes WT, Arnstrong D, Bodey GP, et al. 2002 Guidelines for the use of antimicrobial agents in neutropenic patients with cancer. Clin Infect Dis 2002; 34:730-51.